Women's Health
FDA Office of Women's Health (OWH)
OWH protects and promotes the health of women through policy, science, education, and outreach.
Featured
![OWH_Syphilis graphic](https://public4.pagefreezer.com:443/content/FDA/25-04-2024T12:09/https://www.fda.gov/files/styles/medium_3/public/STI_SpeakerSeries_Syphilis_1600x900_v3_Option2.jpg?itok=y9WRKBpm)
Spolight on Syphilis and Congenital Syphilis
Learn more about syphilis and congenital syphilis—sexually transmitted infections that can cause serious health problems if left untreated.
![National Minority Health Month. Be the Source for Better Health. April 2024 #NMHM2024](https://public4.pagefreezer.com:443/content/FDA/25-04-2024T12:09/https://www.fda.gov/files/styles/medium_3/public/03212024_nmhm_1600x900_final.png?itok=LYiniWPL)
Celebrating National Minority Health Month
National Minority Health Month highlights the importance of improving the health of racial and ethnic minorities and reducing health disparities. Join the FDA in raising awareness about the health issues faced by minority groups and to promote actions to improve health outcomes for everyone.
![Image of pregnant Asian woman working on a laptop](https://public4.pagefreezer.com:443/content/FDA/25-04-2024T12:09/https://www.fda.gov/files/styles/medium_3/public/Asian%20Woman_laptop_web%20resize_CROP_0.jpg?itok=N87yAxNb)
Understanding Pregnancy Exposure Registries
Are you pregnant and taking medicines or received a vaccine? You can help pregnant patients and health care providers understand the effects of medicines and vaccines used during pregnancy by volunteering to enroll in a pregnancy exposure registry study.
![HCP and Patent](https://public4.pagefreezer.com:443/content/FDA/25-04-2024T12:09/https://www.fda.gov/files/styles/medium_3/public/hcpandpatient_web.jpg?itok=IZefxuvi)
Bringing Clinical Research to Patients
This Nov. 8 webinar hosted by OWH and CDER focused on decentralized clinical trials and other novel strategies currently available for bringing clinical research to patients. CME/CNE/CPE available.
![FDA Office of Women's Health Public Workshop Menopause: Potential Impact on Clinical Pharmacology and Opportunities for Future Research](https://public4.pagefreezer.com:443/content/FDA/25-04-2024T12:09/https://www.fda.gov/files/styles/medium_3/public/FDA_OWH_Menopause_EventMaterials_WebGraphic_1600x900_v2.jpg?itok=RCQMf6uu)
Menopause: Potential Impact on Clinical Pharmacology
OWH and CDER/OCP hosted a virtual public workshop to discuss the physiologic changes that occur during menopause and the potential effects of menopause on the pharmacokinetics and pharmacodynamics of drugs.
![Women's Health Research](https://public4.pagefreezer.com:443/content/FDA/25-04-2024T12:09/https://www.fda.gov/files/styles/medium_3/public/Research_0.jpg?itok=o2suDc4y)
Women's Health Research
We promote and conduct research initiatives that advance understanding of sex differences and health conditions unique to women.
Paragraph Header
Contact Us
Office of Women's Health
10903 New Hampshire Ave WO32-2333
Silver Spring, MD 20993